Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach: The FAME 3 Trial

Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach: The FAME 3 Trial

The FAME 3 trial demonstrated that in patients with multivessel disease (MVD) without left main disease, the SYNTAX score threshold for equivalent outcomes between PCI and CABG may be ≤24 rather than ≤22, Dr. Luke P. Dawson, Stanford University School of Medicine, USA, reported in the 26 August issue of JACC: Cardiovascular Interventions.

This study analyzed 1,444 out of 1,500 patients with MVD enrolled in the FAME 3 trial (734 in the PC...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial Program
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial Program
JACC Intervention
Sex Differences in Patients Undergoing FFR-Guided PCI or CABG in the FAME 3 Trial
Sex Differences in Patients Undergoing FFR-Guided PCI or CABG in the FAME 3 Trial
JACC Intervention
Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study
Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study
JACC Intervention
Impact of Balloon-Expandable TAVR Valve Deformation and Calcium Distribution on Outcomes in Bicuspid Aortic Valve: The RESOLVE Trial
Impact of Balloon-Expandable TAVR Valve Deformation and Calcium Distribution on Outcomes in Bicuspid Aortic Valve: The RESOLVE Trial
JACC Intervention
PICK UP
Discover the charm of Japan: Insights from Dr. James Patrick Diaz
Other
Discover the charm of Japan: Insights from Dr. James Patrick Diaz
Message from the Operator: Dr. Yoshihisa Kinoshita
Other
Message from the Operator: Dr. Yoshihisa Kinoshita
Optimal PCI for LMT Bifurcation Lesions: The Toyohashi Style
live video
Optimal PCI for LMT Bifurcation Lesions: The Toyohashi Style
The challenge of complex lesions: The Art of Japanese Intervention
live video
The challenge of complex lesions: The Art of Japanese Intervention
A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan Trial
JACC Intervention
A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan Trial